Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -3.150% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) O=C(CN1CCOCC1)Nc1ccc(-c2nc3ccccc3[nH]2)cc1
b) CC(=O)NS(=O)(=O)c1cccnc1Nc1cccc(Cl)c1
c) Cc1cccc(NC(=O)/C=C/c2ccc([N+](=O)[O-])s2)c1
d) COc1ccc(COC(=O)c2ccc(Cl)c(S(=O)(=O)N3CC(C)OC(C)C3)c2)cc1
e) COc1cccc(C(=O)Nc2ccc(NC(=O)c3ccco3)nc2)c1
Answer: a. O=C(CN1CCOCC1)Nc1ccc(-c2nc3ccccc3[nH]2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CN1CCOCC1)Nc1ccc(-c2nc3ccccc3[nH]2)cc1
O=C(CN1CCOCC1)Nc1ccc(-c2nc3ccccc3[nH]2)cc1
N-[4-(1H-benzimidazol-2-yl)phenyl]-2-morpholin-4-ylacetamide